Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.01 USD | -3.50% | -0.41% | -11.79% |
May. 07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
May. 07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 50.11M | Sales 2025 * | 52.04M | Capitalization | 1.89B |
---|---|---|---|---|---|
Net income 2024 * | -402M | Net income 2025 * | -432M | EV / Sales 2024 * | 22.1 x |
Net cash position 2024 * | 786M | Net cash position 2025 * | 376M | EV / Sales 2025 * | 29.2 x |
P/E ratio 2024 * |
-5.08
x | P/E ratio 2025 * |
-5.08
x | Employees | 346 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.48% |
Latest transcript on Beam Therapeutics Inc.
1 day | -3.50% | ||
1 week | -0.41% | ||
Current month | +13.15% | ||
1 month | -0.37% | ||
3 months | -28.41% | ||
6 months | -18.53% | ||
Current year | -11.79% |
Managers | Title | Age | Since |
---|---|---|---|
John Evans
CEO | Chief Executive Officer | 46 | 16-12-31 |
President | 55 | 18-01-31 | |
Director of Finance/CFO | 47 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Cooper
BRD | Director/Board Member | 54 | 19-10-09 |
John Maraganore
BRD | Director/Board Member | 60 | 21-11-04 |
Mark Fishman
BRD | Director/Board Member | 73 | 18-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.03% | 2 M€ | -25.75% | ||
4.10% | 0 M€ | 0.00% | - | |
4.00% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 24.01 | -3.50% | 912,646 |
24-05-22 | 24.88 | +0.32% | 1,019,839 |
24-05-21 | 24.8 | -0.16% | 971,795 |
24-05-20 | 24.84 | +0.89% | 565,214 |
24-05-17 | 24.62 | +3.49% | 1,332,156 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.79% | 1.96B | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- BEAM Stock